首页> 美国卫生研究院文献>Viruses >A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa
【2h】

A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa

机译:中西部非洲抗正痘病毒抗体的横断面血清学调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Since the eradication of smallpox and the subsequent discontinuation of the worldwide smallpox vaccination program, other Orthopoxviruses beside Variola virus have been increasingly representing a risk to human health. To investigate the extent of natural contact with Orthopoxviruses and possible demographic risk factors for such an exposure, we performed a cross-sectional serosurvey of anti-Orthopoxvirus IgG antibodies in West and Central Africa. To this end, people living in forest regions in Côte d’Ivoire (CIV, n = 737) and the Democratic Republic of the Congo (COD, n = 267) were assigned into groups according to their likely smallpox vaccination status. The overall prevalence of anti-Orthopoxvirus antibodies was 51% in CIV and 60% in COD. High rates of seropositivity among the vaccinated part of the population (80% in CIV; 96% COD) indicated a long-lasting post vaccination immune response. In non-vaccinated participants, seroprevalences of 19% (CIV) and 26% (COD) indicated regular contact with Orthopoxviruses. Multivariate logistic regression revealed that the antibody level in the vaccinated part of the population was higher in COD than in CIV, increased with age and was slightly higher in females than males. In the unvaccinated part of the population none of these factors influenced antibody level significantly. In conclusion, our results confirm expectedly high anti-Orthopoxvirus seroprevalences in previously smallpox-vaccinated people living in CIV and the COD but more unexpectedly imply regular contact with Orthopoxviruses both in Western and Central Africa, even in the absence of recognized outbreaks.
机译:自从根除天花并随后终止全球天花疫苗接种计划以来,除天花病毒外,其他正痘病毒也越来越多地威胁着人类健康。为了调查与正痘病毒的自然接触程度以及此类暴露的可能的人口统计学危险因素,我们在西非和中非进行了抗正痘病毒IgG抗体的横断面血清学调查。为此,根据天花疫苗接种状况,将科特迪瓦(CIV,n = 737)和刚果民主共和国(COD,n = 267)森林地区的人们分为几类。抗正痘病毒抗体的总体患病率在CIV中为51%,在COD中为60%。接种人群中的血清阳性率很高(CIV中为80%; COD为96%),表明疫苗接种后免疫反应持久。在未接种疫苗的参与者中,血清阳性率分别为19%(CIV)和26%(COD),表明他们经常与正痘病毒接触。多元logistic回归分析显示,人群中接种疫苗的人群的抗体水平中,COD高于CIV,随年龄增长而增加,女性略高于男性。在人群中未接种疫苗的部分中,这些因素均未显着影响抗体水平。总之,我们的结果证实了生活在CIV和COD中的以前接种过天花疫苗的人群中预期的抗正痘病毒血清阳性率很高,但出乎意料的是,即使在没有公认的疫情暴发的情况下,也经常与西非正痘病毒定期接触。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号